Skip to main content

Clinical, biochemical, immunogenetic paradigms of Covid-19 infection and their correlation with socio-demographic, etiological, pathogenetic, diagnostic, therapeutically and prognostically important factors to be included in guidelines

Project/agreement No.
VPP-COVID-2020/1-0023
Project funding
497 580.00 EUR, including RSU financing of 347 600 EUR
Project manager
Project realization
01.07.2020. - 31.12.2020.

Aim

To identify the socio-demographic, clinical, biochemical, molecular, and immunological factors of the SARS-CoV-2 infection that affect susceptibility to the virus, the course and outcome of the disease and to improve the efficacy of diagnosing and treatment.

Description

Consortium 6.3. partners

  • Rīga Stradiņš University
  • University of Latvia
  • Latvian Biomedical Research And Study Centre

The aim of the study is to identify the socio-demographic, clinical, biochemical, molecular and immunological factors influencing human susceptibility to the virus, diagnosis of the disease as well as the course, treatment results and post-infectious consequences. It is planned to recruit patients with various degrees of COVID-19 severity and also asymptomatic cases of SARS-CoV-2 infection. Data obtained in Latvian population will be important considering differences in spread of the disease and symptoms in various populations. The data will allow to develop clinical algorithms and guidelines, improve diagnosis and treatment efficacy and reduce lethality. Information obtained will allow us to perform comparative analysis with data from other countries and will allow to adapt World Health Organization’s guidelines in Latvia.